Junya Arima

Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma.

T. Sakaguchi, H. Yoshino, S. Tatarano, 2022, Biochemical and biophysical research communications.

Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma

T. Sakaguchi, H. Yoshino, S. Tatarano, 2023, Cancer science.

Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients

H. Yoshino, R. Matsushita, S. Tatarano, 2023, PloS one.

Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models.

H. Yoshino, R. Matsushita, S. Tatarano, 2024, Molecular oncology.